CN102512603A - Traditional Chinese medicinal composition for treating acute infectious conjunctivitis - Google Patents
Traditional Chinese medicinal composition for treating acute infectious conjunctivitis Download PDFInfo
- Publication number
- CN102512603A CN102512603A CN2011104377319A CN201110437731A CN102512603A CN 102512603 A CN102512603 A CN 102512603A CN 2011104377319 A CN2011104377319 A CN 2011104377319A CN 201110437731 A CN201110437731 A CN 201110437731A CN 102512603 A CN102512603 A CN 102512603A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- flos
- chinese medicinal
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicinal composition for treating acute infectious conjunctivitis. The traditional Chinese medicinal composition comprises, by weight, 5-25 parts of honeysuckle flower, 5-20 parts of Weeping Forsythia, 5-20 parts of Lophatherum gracile, 4-10 parts of licorice, 5-20 parts of Cypripedium margaritaceum Franch, 5-20 parts of chrysanthemum, 5-20 parts of Equisetum ramosissimum, 5-20 parts of Herba Houttuyniae, 5-20 parts of Fructus Viticis, 5-20 parts of coptis, 5-20 parts of periostracum cicadae and 5-20 parts of Flos Buddlejae. The traditional Chinese medicinal composition which has the efficacies of heat clearing and detoxifying, liver clearing and eyesight improving, wind dispelling and heat radiating, and liver calming and kidney solidifying has the advantages of substantial acute curing infectious conjunctivitis effect, reliable effect, wide component medicine sources, simple preparation, mild medicinal property, and no toxic side effect.
Description
Technical field
The present invention relates to a kind of medicinal preparation of not confirming structure of traditional herbal medicines, especially a kind of Chinese medicine composition of treating pink-eye.
Background technology
The general designation of the conjunctivitis inflammatory reaction that to be conjunctival tissue take place in the effect of extraneous and body oneself factor.Though conjunctivitis itself is general and not serious to eyesight influence, when its inflammation involves cornea or leads to complications, can cause the infringement of vision.Conjunctivitis is an ephemeral infectious disease, occurs in summer and autumn well, and infectiousness is extremely strong, but normal outbreak of epidemic.Conjunctivitis itself is general and not serious to eyesight influence, but when its inflammation involves cornea or leads to complications, can cause the infringement of vision, even blind.Pink-eye is commonly called as blood-shot eye illness disease, can be caused by various antibacterial or filtration virus infection.At present, change the therapeutic treatment pink-eye can be with normal saline or the flushing of 3% boric acid water, every day 2～3 times at present; Can pain relieving and alleviate edema; Simultaneously, drip and use the antibiotic collyrium, if viral infection is just used the antiviral collyrium; The eye dripping number of times must be frequent, is preferably one hour 1 time.The local cold compress of the person of being in a bad way adds with whole body and uses antibiotic or antiviral drugs.There is the deficiency of troublesome poeration.
Chinese medicine is traditional good recipe of the Chinese nation.And Chinese medicine warm in nature with have no side effect, curative effect is obvious.The traditional Chinese medical science thinks that pink-eye system is by experiencing the ailment said due to cold or exposure pyretic toxicity, and invasion and attack human body eye causes.Sick the lighter is for attacking on the wind heat
,Seriously ill person is that fire-toxin is flourishing
The traditional Chinese medical science adopts heat-clearing and toxic substances removing, dispelling wind for relieving itching therapy often to obtain good effect.
According to theory of Chinese medical science, to the pathogeny of pink-eye, carry out dialectical composition of prescription, to reach the purpose of treating both the principal and secondary aspects of a disease.
Summary of the invention
Technical problem to be solved by this invention provides and a kind ofly prepares conveniently, the medicine source is wide, cost is low, evident in efficacy, reliable effect, a kind of Chinese medicine composition of treating pink-eye of having no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition of treating pink-eye is characterized in that: it is made up of following Chinese medicinal raw materials in portion by weight: Flos Lonicerae 5-25 part, Fructus Forsythiae 5-20 part, Herba Lophatheri 5-20 part, Radix Glycyrrhizae 4-10 part, Herba Cyperipedii Margaritacei 5-20 part, Flos Chrysanthemi 5-20 part, Herba Clinopodii Polycephali 5-20 part, Herba Houttuyniae 5-20 part, Fructus Viticis 5-20 part, Rhizoma Coptidis 5-20 part, Periostracum Cicadae 5-20 part, Flos Buddlejae 5-20 part.
Optimal technical scheme of the present invention is: a kind of Chinese medicine composition of treating pink-eye is characterized in that: it is made up of following Chinese medicinal raw materials in portion by weight: 15 parts of Flos Loniceraes, 10 parts of Fructus Forsythiaes, 10 parts of Herba Lophatheris, 6 parts in Radix Glycyrrhizae, 10 parts of Herba Cyperipedii Margaritaceis, 12 parts of Flos Chrysanthemis, 10 parts of Herba Clinopodii Polycephalies, 10 parts of Herba Houttuyniae, 10 parts of Fructus Viticises, 10 parts of Rhizoma Coptidis, 10 parts of Periostracum Cicadaes, 10 parts of Flos Buddlejaes.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience guidance, selected medicament composing prescription.In the present invention in the drug composition: Flos Lonicerae has the effect of heat-clearing and toxic substances removing; Fructus Forsythiae has the effect of heat-clearing and toxic substances removing, mass dissipating and swelling eliminating; Herba Lophatheri has clearing heat and relieving fidgetness, diuretic effect; Radix Glycyrrhizae has the effect of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, coordinating the actions of various ingredients in a prescription; Herba Cyperipedii Margaritacei has the liver and the kidney tonifying, the diuretic effect makes eye bright; Flos Chrysanthemi has that dispelling wind and heat pathogens, suppressing the hyperactive liver make eye bright, the effect of heat-clearing and toxic substances removing; Herba Clinopodii Polycephali has the effect of clearing away heat and promoting diuresis, improving acuity of vision and removing nebula; Herba Houttuyniae has heat-clearing and toxic substances removing, evacuation of pus diuretic effect; Fructus Viticis has dispelling wind and heat pathogens, the clear sharp head's effect; Rhizoma Coptidis has the effect of heat clearing and damp drying, eliminating fire and detoxication; Periostracum Cicadae has the effect of diffusing wind heat extraction; Flos Buddlejae has the effect of heat clearing away nourishing the liver, improving acuity of vision and removing nebula.Drug component in the present composition is through dialectical compatibility, complements each other using, and has synergism, plays the effect that heat-clearing and toxic substances removing, liver heat removing and eyesight improving, wind-dispelling heat-dissipating, suppressing the hyperactive liver reinforce the kidney altogether, thereby reaches the purpose of treatment pink-eye.
The component of the present composition all adopts natural raw material of Chinese medicine, and its simple and convenient preparation, the medicine source is wide, cost is low.It follows the prescription principle of medication of the traditional Chinese medical science, and various component drug adopt the usefulness that is decocted in water for oral dose.Through the clinical practice checking, it is evident in efficacy, reliable effect, and the property of medicine is gentle, toxic and side effects do not occur, and effective percentage reaches 92.3%, and cure rate reaches 69.2%.
The specific embodiment
Below in conjunction with embodiment the present invention is further specified.
Embodiment 1
A kind of Chinese medicine composition of treating pink-eye, it is made up of following Chinese medicine raw materials by weight proportion: Flos Lonicerae 15g, Fructus Forsythiae 10g, Herba Lophatheri 10g, Radix Glycyrrhizae 6g, Herba Cyperipedii Margaritacei 10g, Flos Chrysanthemi 12g, Herba Clinopodii Polycephali 10g, Herba Houttuyniae 10g, Fructus Viticis 10g, Rhizoma Coptidis 10g, Periostracum Cicadae 10g, Flos Buddlejae 10g.
Embodiment 2
A kind of Chinese medicine composition of treating pink-eye, it is made up of following Chinese medicine raw materials by weight proportion: Flos Lonicerae 25g, Fructus Forsythiae 12g, Herba Lophatheri 5g, Radix Glycyrrhizae 4g, Herba Cyperipedii Margaritacei 20g, Flos Chrysanthemi 10g, Herba Clinopodii Polycephali 5g, Herba Houttuyniae 20g, Fructus Viticis 12g, Rhizoma Coptidis 12g, Periostracum Cicadae 5g, Flos Buddlejae 15g.
Embodiment 3
A kind of Chinese medicine composition of treating pink-eye, it is made up of following Chinese medicine raw materials by weight proportion: Flos Lonicerae 12g, Fructus Forsythiae 25g, Herba Lophatheri 15g, Radix Glycyrrhizae 8g, Herba Cyperipedii Margaritacei 5g, Flos Chrysanthemi 5g, Herba Clinopodii Polycephali 20g, Herba Houttuyniae 15g, Fructus Viticis 20g, Rhizoma Coptidis 20g, Periostracum Cicadae 12g, Flos Buddlejae 20g.
Embodiment 4
A kind of Chinese medicine composition of treating pink-eye, it is made up of following Chinese medicine raw materials by weight proportion: Flos Lonicerae 5g, Fructus Forsythiae 20g, Herba Lophatheri 20g, Radix Glycyrrhizae 6g, Herba Cyperipedii Margaritacei 15g, Flos Chrysanthemi 15g, Herba Clinopodii Polycephali 12g, Herba Houttuyniae 12g, Fructus Viticis 5g, Rhizoma Coptidis 15g, Periostracum Cicadae 15g, Flos Buddlejae 12g.
Embodiment 5
A kind of Chinese medicine composition of treating pink-eye, it is made up of following Chinese medicine raw materials by weight proportion: Flos Lonicerae 10g, Fructus Forsythiae 15g, Herba Lophatheri 12g, Radix Glycyrrhizae 10g, Herba Cyperipedii Margaritacei 12g, Flos Chrysanthemi 20g, Herba Clinopodii Polycephali 15g, Herba Houttuyniae 5g, Fructus Viticis 15g, Rhizoma Coptidis 5g, Periostracum Cicadae 20g, Flos Buddlejae 5g.
Chinese medicine composition in the embodiment of the invention is produced medicament by the decocting method of routine.Concrete grammar is following: the raw material of Chinese medicine of prescription is put into container, add cold water and cover powder, soaked 15～20 minutes, add water again and do not have about 8 centimetres of powder, decoct.Adopt intense fire to decoct at a simmer, the back of boiling was with slow fire boiling 20～30 minutes; Second decocts, and decocts 15～20 minutes after water boils.Twice decoction extracting juice that removes slag merges.
A kind of Chinese medicine composition of treating pink-eye, clinical efficacy is summed up:
One, general data: this Chinese medicine composition is applied to clinical observation case 26 examples, male 23 examples, and women 3 examples, at 8～44 years old age, the course of disease is the shortest 3 days, and is the longest 1 month.
Two, usage and dosage: during clinical practice, the component in the compositions, consumption are taken the circumstances into consideration increase and decrease according to patient's body weight, age and symptom.Potion on the one, the about 300ml of twice extracting juice of decocting divides early, takes for late twice.Three days is a course of treatment.Pungent stimulation food and drinks such as period in a medicine diet cigarette, wine, seafood, chaffy dish, spicy string.
Three, criterion of therapeutical effect:
(1) recovery from illness: transference cure or significantly alleviate, secretions and hyperemia are disappeared;
(2) take a turn for the better: doing well,improving, conjunctival congestion alleviates;
(3) invalid: no change before and after the treatment.
Four, therapeutic effect: in this clinical observation case, take medicine 1-5 the course of treatment 18 examples of fully recovering, 6 examples that take a turn for the better, invalid 2 examples.Toxic and side effects does not take place during the treatment.
Five, model case:
Case 1:
Lin, man, 16 years old.Eyes are red and swollen, companion's ophthalmalgia, ophthalmic pruritus, and photophobia is shed tears, red tongue with thin and yellow fur, wiry and frequent pulse, yellow urine, constipation.Take 1 course of treatment of medicament of Chinese medicine composition preparation of the present invention, the furious alleviation of pain that swells, itches is light; Continue and obey two courses of treatment, all diseases disappear, and cure.
Case 2:
Xiao, man, 25 years old.Sick furious red, very to itch unbearably, slight photophobia is shed tears haircuts shape secretions.Take 1 course of treatment of medicament of Chinese medicine composition of the present invention preparation, sx, continuous clothes be after 2 courses of treatment, transference cure; Give consolidating to continue to obey again and treat 1 course of treatment, it is normal that eyes recover, healing.
Claims (2)
1. Chinese medicine composition of treating pink-eye, it is characterized in that: it is made up of following Chinese medicinal raw materials in portion by weight: Flos Lonicerae 5-25 part, Fructus Forsythiae 5-20 part, Herba Lophatheri 5-20 part, Radix Glycyrrhizae 4-10 part, Herba Cyperipedii Margaritacei 5-20 part, Flos Chrysanthemi 5-20 part, Herba Clinopodii Polycephali 5-20 part, Herba Houttuyniae 5-20 part, Fructus Viticis 5-20 part, Rhizoma Coptidis 5-20 part, Periostracum Cicadae 5-20 part, Flos Buddlejae 5-20 part.
2. a kind of Chinese medicine composition of treating pink-eye according to claim 1, it is characterized in that: it is made up of following Chinese medicinal raw materials in portion by weight: 15 parts of Flos Loniceraes, 10 parts of Fructus Forsythiaes, 10 parts of Herba Lophatheris, 6 parts in Radix Glycyrrhizae, 10 parts of Herba Cyperipedii Margaritaceis, 12 parts of Flos Chrysanthemis, 10 parts of Herba Clinopodii Polycephalies, 10 parts of Herba Houttuyniae, 10 parts of Fructus Viticises, 10 parts of Rhizoma Coptidis, 10 parts of Periostracum Cicadaes, 10 parts of Flos Buddlejaes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110437731 CN102512603B (en) | 2011-12-23 | 2011-12-23 | Traditional Chinese medicinal composition for treating acute infectious conjunctivitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110437731 CN102512603B (en) | 2011-12-23 | 2011-12-23 | Traditional Chinese medicinal composition for treating acute infectious conjunctivitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102512603A true CN102512603A (en) | 2012-06-27 |
| CN102512603B CN102512603B (en) | 2013-12-25 |
Family
ID=46283855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110437731 Expired - Fee Related CN102512603B (en) | 2011-12-23 | 2011-12-23 | Traditional Chinese medicinal composition for treating acute infectious conjunctivitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102512603B (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102895346A (en) * | 2012-09-07 | 2013-01-30 | 马彩燕 | Fumigating medicament for treating conjunctivitis |
| CN104888016A (en) * | 2015-06-18 | 2015-09-09 | 王峰 | Traditional Chinese medicine preparation for treating conjunctivitis and preparation method of traditional Chinese medicine preparation |
| CN104940686A (en) * | 2015-06-18 | 2015-09-30 | 王峰 | Chinese medicinal formula for treating conjunctivitis |
| CN104940384A (en) * | 2015-07-17 | 2015-09-30 | 江苏苏南药业实业有限公司 | Traditional Chinese medicine combination for treating conjunctivitis and preparation method thereof |
| CN105106703A (en) * | 2015-09-02 | 2015-12-02 | 宋琳 | Traditional Chinese medicine preparation for treating acute catarrhal conjunctivitis and nursing method |
| CN105311438A (en) * | 2014-06-25 | 2016-02-10 | 张红伶 | Medicine for treating acute conjunctivitis |
| CN106075306A (en) * | 2016-07-29 | 2016-11-09 | 安徽新盛中药饮片有限公司 | A kind of Chinese medicine treating acute conjunctivitis |
| CN109394987A (en) * | 2018-12-06 | 2019-03-01 | 中山大学中山眼科中心 | The composition and preparation method thereof with treatment eye disease containing dimethyl fumarate |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1177492A (en) * | 1997-10-21 | 1998-04-01 | 陈新学 | Medicine for preventing and treating eye diseases |
| CN101953950A (en) * | 2010-10-18 | 2011-01-26 | 曾蕊 | Chinese medicament for treating viral keratitis |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100361170B1 (en) * | 2000-02-10 | 2002-11-18 | 주식회사 케이티프리텔 | System and method for transmitting text art |
-
2011
- 2011-12-23 CN CN 201110437731 patent/CN102512603B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1177492A (en) * | 1997-10-21 | 1998-04-01 | 陈新学 | Medicine for preventing and treating eye diseases |
| CN101953950A (en) * | 2010-10-18 | 2011-01-26 | 曾蕊 | Chinese medicament for treating viral keratitis |
Non-Patent Citations (2)
| Title |
|---|
| 廖华: "解毒法在眼科临床的运用", 《中国中医眼科杂志》 * |
| 许伟华: "中药浸膏颗粒剂治疗流行性角、结膜炎的疗效观察", 《新中医》 * |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102895346A (en) * | 2012-09-07 | 2013-01-30 | 马彩燕 | Fumigating medicament for treating conjunctivitis |
| CN102895346B (en) * | 2012-09-07 | 2016-08-03 | 富阳原野生物科技有限公司 | A kind of fumigation-washing medicine treating conjunctivitis |
| CN105311438A (en) * | 2014-06-25 | 2016-02-10 | 张红伶 | Medicine for treating acute conjunctivitis |
| CN104888016A (en) * | 2015-06-18 | 2015-09-09 | 王峰 | Traditional Chinese medicine preparation for treating conjunctivitis and preparation method of traditional Chinese medicine preparation |
| CN104940686A (en) * | 2015-06-18 | 2015-09-30 | 王峰 | Chinese medicinal formula for treating conjunctivitis |
| CN104940384A (en) * | 2015-07-17 | 2015-09-30 | 江苏苏南药业实业有限公司 | Traditional Chinese medicine combination for treating conjunctivitis and preparation method thereof |
| CN105106703A (en) * | 2015-09-02 | 2015-12-02 | 宋琳 | Traditional Chinese medicine preparation for treating acute catarrhal conjunctivitis and nursing method |
| CN106075306A (en) * | 2016-07-29 | 2016-11-09 | 安徽新盛中药饮片有限公司 | A kind of Chinese medicine treating acute conjunctivitis |
| CN109394987A (en) * | 2018-12-06 | 2019-03-01 | 中山大学中山眼科中心 | The composition and preparation method thereof with treatment eye disease containing dimethyl fumarate |
| CN109394987B (en) * | 2018-12-06 | 2021-03-23 | 中山大学中山眼科中心 | Composition containing dimethyl fumarate for treating eye diseases and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102512603B (en) | 2013-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102512603B (en) | Traditional Chinese medicinal composition for treating acute infectious conjunctivitis | |
| CN103386008B (en) | Chinese medicine composition for treating endocrine dyscrasia | |
| CN103223118B (en) | Traditional Chinese medicine composition for treating facial paralysis | |
| CN105288208A (en) | Traditional Chinese medicine composition for treating acute optic neuritis | |
| CN101167884B (en) | Orally-administered traditional Chinese medicinal formula for treating cataract | |
| CN102670993B (en) | Traditional Chinese medicine for treating cataract | |
| CN103211962B (en) | Chinese medicinal composition for treating anhypnia | |
| CN104623232A (en) | Traditional Chinese medicine composition for treating tinnitus | |
| CN104474298A (en) | Traditional Chinese medicine for treating vitiligo | |
| CN102349957A (en) | Traditional Chinese medicine composition for treating prurigo | |
| CN104784458A (en) | Traditional Chinese medicine composition for treating insomnia | |
| CN104784417A (en) | Traditional Chinese medicine composition for curing impotentia | |
| CN103028063B (en) | Traditional Chinese medicine composition for treating nephropathy | |
| CN103721028B (en) | One treats anginal medicine and preparation method | |
| CN103211998B (en) | Traditional Chinese medicine composition for treatment of yin deficiency and yang excess | |
| CN103223113B (en) | Traditional Chinese medicine composition for treating functional uterine bleeding | |
| CN103285108B (en) | Chinese medicinal composition treating lumbago | |
| CN102284035A (en) | Chinese composition for treating rhinitis | |
| CN102949653B (en) | Traditional Chinese medicine composition for treating scapulohumeral periarthritis | |
| CN105687775A (en) | Traditional Chinese medicine composition for treating keratohelcosis | |
| CN105833094A (en) | Traditional Chinese medicine composition for treating trachoma | |
| CN105560818A (en) | Medicine for treating cataract and preparation method thereof | |
| CN104367896A (en) | Pharmaceutical composition for treating qi deficiency and blood stasis-type apoplexy and preparation method thereof | |
| CN104524036A (en) | Traditional Chinese medicine preparation for treating optic neuritis and preparation method thereof | |
| CN105287950A (en) | Traditional Chinese medicine composition for treating allergic conjunctivitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: CUI HONGMEI Free format text: FORMER OWNER: RONGCHENG YATOU MEIQUAN DENTAL CLINIC Effective date: 20131018 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Cui Hongmei Inventor after: Liu Hui Inventor before: Liu Hui |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LIU HUI TO: CUI HONGMEI LIU HUI Free format text: CORRECT: ADDRESS; FROM: 264300 WEIHAI, SHANDONG PROVINCE TO: 264309 WEIHAI, SHANDONG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20131018 Address after: 264309 No. 16 Qinglong Road, Rongcheng Harbour Road, Shandong, Weihai Applicant after: Cui Hongmei Address before: 264300, No. 91, building No. 11, lotus pond North District, Weihai City, Shandong, Rongcheng Applicant before: Rongcheng Yatou Meiquan Dental Clinic |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131225 Termination date: 20141223 |
|
| EXPY | Termination of patent right or utility model |